Sampre Nutritions [SAMPRE] vs Balrampur Chini [BALRAMCHIN] Detailed Stock Comparison

Sampre Nutritions
BSE
Loading...

Balrampur Chini
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sampre Nutritions wins in 6 metrics, Balrampur Chini wins in 13 metrics, with 0 ties. Balrampur Chini appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Sampre Nutritions | Balrampur Chini | Better |
---|---|---|---|
P/E Ratio (TTM) | 151.31 | 25.28 | Balrampur Chini |
Price-to-Book Ratio | 1.40 | 2.90 | Sampre Nutritions |
Debt-to-Equity Ratio | 18.60 | 69.21 | Sampre Nutritions |
PEG Ratio | -0.13 | -1.38 | Balrampur Chini |
EV/EBITDA | -42.40 | 19.35 | Sampre Nutritions |
Profit Margin (TTM) | -22.45% | 8.07% | Balrampur Chini |
Operating Margin (TTM) | 9.03% | 21.42% | Balrampur Chini |
EBITDA Margin (TTM) | 9.03% | 21.42% | Balrampur Chini |
Return on Equity | -8.44% | 12.14% | Balrampur Chini |
Return on Assets (TTM) | -6.65% | 5.03% | Balrampur Chini |
Free Cash Flow (TTM) | $-1.93M | $-4.67B | Sampre Nutritions |
Dividend Yield | N/A | 0.51% | N/A |
1-Year Return | -20.73% | 11.04% | Balrampur Chini |
Price-to-Sales Ratio (TTM) | 4.06 | 2.03 | Balrampur Chini |
Enterprise Value | $1.43B | $136.30B | Balrampur Chini |
EV/Revenue Ratio | 4.55 | 2.52 | Balrampur Chini |
Gross Profit Margin (TTM) | 63.47% | 42.23% | Sampre Nutritions |
Revenue per Share (TTM) | $13 | $268 | Balrampur Chini |
Earnings per Share (Diluted) | $-5.20 | $21.57 | Balrampur Chini |
Beta (Stock Volatility) | -0.34 | 0.64 | Sampre Nutritions |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sampre Nutritions vs Balrampur Chini Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Sampre Nutritions | 2.00% | 10.37% | 56.84% | 152.01% | 63.64% | -3.40% |
Balrampur Chini | -0.90% | -3.19% | -8.71% | 0.97% | 18.77% | -0.01% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Sampre Nutritions | -20.73% | -19.42% | 334.00% | 547.07% | 738.07% | 124.62% |
Balrampur Chini | 11.04% | 60.68% | 283.40% | 1,031.12% | 548.28% | 505.44% |
Performance & Financial Health Analysis: Sampre Nutritions vs Balrampur Chini
Metric | SAMPRE | BALRAMCHIN |
---|---|---|
Market Information | ||
Market Cap | ₹1.28B | ₹110.08B |
Market Cap Category | Small cap | Mid cap |
10 Day Avg. Volume | 117,131 | 242,685 |
90 Day Avg. Volume | 122,116 | 294,076 |
Last Close | ₹60.76 | ₹545.20 |
52 Week Range | ₹20.90 - ₹101.17 | ₹419.05 - ₹691.80 |
% from 52W High | -39.94% | -21.19% |
All-Time High | ₹296.35 (Oct 17, 2022) | ₹691.80 (Sep 30, 2024) |
% from All-Time High | -79.50% | -21.19% |
Growth Metrics | ||
Quarterly Revenue Growth | 1.41% | 0.05% |
Quarterly Earnings Growth | 6.16% | 0.13% |
Financial Health | ||
Profit Margin (TTM) | -0.22% | 0.08% |
Operating Margin (TTM) | 0.09% | 0.21% |
Return on Equity (TTM) | -0.08% | 0.12% |
Debt to Equity (MRQ) | 18.60 | 69.21 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹43.25 | ₹188.02 |
Cash per Share (MRQ) | ₹0.11 | ₹0.17 |
Operating Cash Flow (TTM) | ₹-42,781,000 | ₹4.25B |
Levered Free Cash Flow (TTM) | ₹-76,723,000 | ₹-7,110,308,352 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.51% |
Last 12-Month Dividend | N/A | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Sampre Nutritions vs Balrampur Chini
Metric | SAMPRE | BALRAMCHIN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 151.31 | 25.28 |
Forward P/E | N/A | 16.64 |
PEG Ratio | -0.13 | -1.38 |
Price to Sales (TTM) | 4.06 | 2.03 |
Price to Book (MRQ) | 1.40 | 2.90 |
Market Capitalization | ||
Market Capitalization | ₹1.28B | ₹110.08B |
Enterprise Value | ₹1.43B | ₹136.30B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.55 | 2.52 |
Enterprise to EBITDA | -42.40 | 19.35 |
Risk & Other Metrics | ||
Beta | -0.34 | 0.64 |
Book Value per Share (MRQ) | ₹43.25 | ₹188.02 |
Financial Statements Comparison: Sampre Nutritions vs Balrampur Chini
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SAMPRE | BALRAMCHIN |
---|---|---|
Revenue/Sales | ₹108.57M | ₹15.04B |
Cost of Goods Sold | ₹39.65M | ₹8.69B |
Gross Profit | ₹68.91M | ₹6.35B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹9.81M | ₹3.22B |
EBITDA | ₹14.08M | ₹3.85B |
Pre-Tax Income | ₹7.08M | ₹3.12B |
Income Tax | ₹0 | ₹825.75M |
Net Income (Profit) | ₹7.08M | ₹2.29B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SAMPRE | BALRAMCHIN |
---|---|---|
Cash & Equivalents | ₹2.32M | ₹3.57M |
Total Current Assets | ₹154.75M | ₹33.01B |
Total Current Liabilities | ₹132.17M | ₹25.57B |
Long-Term Debt | ₹105.85M | ₹4.90B |
Total Shareholders Equity | ₹908.76M | ₹37.96B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹198.59M | ₹26.45B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SAMPRE | BALRAMCHIN |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SAMPRE | BALRAMCHIN |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 117,131 | 242,685 |
Average Daily Volume (90 Day) | 122,116 | 294,076 |
Shares Outstanding | 17.96M | 201.90M |
Float Shares | 7.28M | 118.01M |
% Held by Insiders | 0.53% | 0.41% |
% Held by Institutions | 0.10% | 0.34% |
Dividend Analysis & Yield Comparison: Sampre Nutritions vs Balrampur Chini
Metric | SAMPRE | BALRAMCHIN |
---|---|---|
Last 12-Month Dividend | N/A | ₹3.00 |
Last 12-Month Dividend Yield | N/A | 0.51% |
3-Year Avg Annual Dividend | N/A | ₹2.83 |
3-Year Avg Dividend Yield | N/A | 0.62% |
3-Year Total Dividends | N/A | ₹8.50 |
Ex-Dividend Date | N/A | Nov 25, 2024 |